Skip to main content

International Journal of Phytomedicine and Phytotherapy

Table 6 Changes in patients bacteriuria spectrum

From: An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections (uUTIs)

  Day 0 Day 7 Day 37
N % N % N %
Patients 125 100 122 100 121 100
Patients with significant bacteriuria 65 52.0 65 53.3 61 50.4
Total isolates 87 100 83 100 79 100
E.coli 35 40.2 36 43.4 31 39.2
Klebsiella spp. 4 4.6 4 4.8 4 5.1
Proteus spp. 3 3.4 2 2.4 5 6.3
Other Enterobacteriaceae 1 1.1 3 3.6 2 2.5
Enterococci 34 39.1 28 33.7 32 40.5
Staphylococci 4 4.6 4 4.8 3 3.8
Streptococci 1 1.1 2 2.4 0 0.0
Other Gram positives 5 5.7 4 4.8 2 2.5
  1. Number (N) and percentage (%) of patients with significant bacteriuria (≥ 103 colony forming units (CFU)/ml) on Day 0, Day 7 and Day 37 and the respective spectrum of uropathogens